GlassScriptPhysician profile
Charles Melbern Wilcox
NPI 1740297027
$1,159.25
in general payments reported to CMS, 2019-2025
13 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $45.31 · 2021: $16.74 · 2022: $79.59 · 2023: $336 · 2024: $518 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,017.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $266.35 | 2024-2025 | Terlivaz |
| Abbvie INC. | $205.16 | 2020-2025 | Linzess, Viberzi, Creon |
| Takeda Pharmaceuticals U.S.A., INC. | $195.35 | 2022-2024 | Entyvio |
| Pentax of America, INC. | $111.63 | 2020-2024 | Pentax Medical, C2 Cryoballoon Focal Controller, C2 Cryoballoon |
| Janssen Biotech, INC. | $101.32 | 2021-2024 | Stelara |
| Olympus America INC. | $98.85 | 2023 | Evis Exera III Gastrointestinal Videoscope |
| Genzyme Corporation | $50.69 | 2023 | |
| Lilly USA, LLC | $37.19 | 2024 | Omvoh |
| Mauna Kea Technologies, INC. | $26.00 | 2024 | |
| Braintree Laboratories, INC. | $25.03 | 2024 | Sutab, Suflave |
| Medtronic, INC. | $15.81 | 2024 | Interstim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.52 | 2020 | |
| Evoke Pharma, INC. | $12.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Wilcox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.